AUTOIMMUNITY IN VITILIGO: RELATIONSHIP WITH HLA, Gm AND Km POLYMORPHISMS

References

• Brostoff J, Bor S, Fciwel M. Autoantibodies in patients with vitiligo. Lancet 1969; ii: 177–178
   Google Scholar
• Korkji W, Solatani K, Simjee S, Marcincin P G, Chu‐ang Tsu‐Yi. Tissue specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cut Pathol 1984; 11: 522–530
   Google Scholar
• Betterle C, Caretto A, De Zio A, Pedini B, Veller‐Fornasa C, Cecchetto A, et al. Incidence and significance of organ‐specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985; 171: 419–423
   Google Scholar
• Bystryn J C. Immune mechanisms in vitiligo. Immune Mechanisms in Cutaneous Disease, D A Norris. Marcel Dekkerlnc., New York and Basel 1989; 447–473
   Google Scholar
• Bystryn J C. Serum antibodies in vitiligo patients. Disorders of pigmentation. Clinics in dermatology, R M Mackic. J.B. Lippincott, Philadelphia 1989; 7: 136–145
   Google Scholar
• Hertz K C, Gazze L A, Kirkpatrick C H, Katz S I. Autoimmune vitiligo: Detection of antibodies to melanin‐producing cells. N Engl J Med 1977; 297: 634–637
   PubMed Web of Science ®Google Scholar
• Naughton G K, Eisinger M, Bystryn J C. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81: 540–542
   PubMed Web of Science ®Google Scholar
• Betterle C, Mirakian R, Doniach D, Bottazzo G F, Riley W, MacLaren N K. Antibodies to melanocytes in vitiligo. Lancet 1984; i: 159
   Google Scholar
• Grimes P E, Mamdooh G, Stockton T, Payne C, Kelly P, Alfred L. T cell profiles in vitiligo. J Am Acad Dermatol 1986; 14: 196–201
   PubMed Web of Science ®Google Scholar
• Mozzanica N, Frigerio U, Finzi A F, Cattaneo A, Negri M, Sca‐glione F, et al. T cell subpopulation in vitiligo: a chronobiol‐ogic study. J Am Acad Dermatol 1990; 22: 223–230
   PubMedGoogle Scholar
• Chapters 4–5. HLA and Disease Associations, J L Tiwari, P I Terasaki. Springer‐Verlag, Inc., New York 1985; 28–48
   Google Scholar
• Shoenfeld Y, Isenberg D A. The mosaic of autoimmunity. Immunol Today 1989; 10(4)123–126
   PubMedGoogle Scholar
• Finco O, Cuccia M, Martinetti M, Ruberto G, Orecchia G, Rab‐biosi G. Age of onset in vitiligo: relationship with HLA supra‐types. Clinical Genetics 1991; 39: 48–54
   PubMed Web of Science ®Google Scholar
• Pandey J P, Fudenberg H H. Perspectives on the genetics of the Gm system and its role in immune response and diseases. Clinics in Immunology and Allergy 1984; 4(3)641–645
   Google Scholar
• Nakao Y, Matsumoto H, Miyazaki T, Mizuno N, Arima N, Wakisaka A, et al. IgG heavy‐chain allotypes (Gm) in autoimmune diseases. Clin Experim Immunol 1980; 42: 20–26
   PubMed Web of Science ®Google Scholar
• Farid N R, Newton M R, Noel E P, Marshall W H. Gm pheno‐types in autoimmune thyroid diseases. J Immunogenet 1977; 4: 429–432
   PubMedGoogle Scholar
• Bottazzo G F, Doniach D. Autoimmunity e sindromi poliendo‐crinopatiche. Min Endocrin 1981; 6: 73–94
   Google Scholar
• Lorini R, Larizza D, Livieri C, Cammareri V, Martini A, Pleb‐ani A, et al. Autoimmunity in children with Diabetes mellitus and in their relatives. Eur J Pediatr 1986; 145: 182–184
   Google Scholar
• Alper C A, Boenisch T, Watson L. Genetic polymorphism in human glycine‐rich beta glycoproteins. J Exp Med 1972; 135: 68–80
   PubMed Web of Science ®Google Scholar
• Awdeh Z L, Alper C A. Inherited structural polymorphism of the fourth component of human complement. PNAS 1980; 77: 3576–3580
   PubMed Web of Science ®Google Scholar
• Field L L, Dugoujon J M. Immunoglobulin allotyping (Gm, Km) of GAW 5 families. Genet. Epidemiol 1989; 57: 133–136
   Google Scholar
• Dugoujon J M, de Lange G, Blancher A, Alie‐Daran S, Marty Y. Characterization of an Ig G2 G2m (23) anti‐Rh‐D antibody. Vox Sanguinis 1989; 57: 133–136
   Google Scholar
• Lorini R, Avanzini M A, Soardo S, Cortona L, D'Annunzio G, Severi F. Antigliadin and anti‐beta‐lactoglobulin antibodies in children with Type 1 (insulin‐dependent) diabetes mellitus. Harm Res 1990; 33: 215
   Google Scholar
• Haider R M, Grimes P E, Cowan C A, Enterline J A, Chakrabarti S G, Kenney J A. Childhood vitiligo. J Am Acad Dermatol 1987; 16: 948–954
   Google Scholar
• Nakao Y, Sasazuki T. Gm and disease. Handbook of Experimental Immunology, D M Weir. Blackwell Scientific, Boston 1986; Vol 3: 96.01–96.10
   Google Scholar
• De Marchi M, Carbonara A O, Mayr W R, van Loghem E, De Lange G G, Ansaldi N, . HLA.‐DR, Gm allotypes and sex as risk factors for coeliac disease. Histocompatibility Testing, E D Albert, M P Baur, W R Mayer, et al. Springer‐Ver‐lag, Heidelberg 1984; 665, 1984
   Google Scholar
• Dizier M H, Deschamps I, Hors J, Blanc M, Rivat L, Clerget‐Darpoux F. Interactive effect of HLA and Gm tested in a study of 135 juvenile insulin‐dependent diabetic families. Tissue Antigens 1986; 27: 269–278
   Google Scholar
• Galbraith G MP, Pandey J P. Kml allotype association with one subgroup of alopecia areata. Am J Hum Genet 1989; 44: 426–428
   Google Scholar
• Martinetti M, Tafi A, Dugoujon J M, Mazzacane D, Blanc M. Cuccia Belvedere M. Possible interaction between HLA and Ig light‐chain markers in susceptibility to uveitis. Disease Markers 1988; 6: 257–262
   Google Scholar
• Retornaz G, Betuel H, Ortonne J P, Thivolet J. HL.‐A antigens and vitiligo. Br J Dermatol 1976; 95: 173
   Google Scholar
• Larizza D, Martinetti Bianchi M, Lorini R, Maghnie M, Dugoujon J M, Belvedere Cuccia M, Severi F. Autoimmunity. HLA. Gm and Km polymorphisms in Turner's syndrome. Autoimmunity 1989; 4: 69–78
   PubMed Web of Science ®Google Scholar